Senate Bill Would Overhaul Medicare Drug Middlemen, Require Full Rebate Pass-Through to Patients
A senate committee must act next: committee consideration.
No action since March 2025
Scores run from -100 (strongly harmful) to +100 (strongly beneficial) for each group, combining impact, certainty, scope, and duration ratings of 1-5. How impact scoring works
Independent pharmacies, many of which are small businesses, stand to benefit significantly. The bill's "any willing pharmacy" rule means drug plans must accept any pharmacy that meets standard terms, preventing PBMs from shutting out local pharmacies in favor of their own mail-order or specialty affiliates. New protections against unfair contract terms, a government complaint process, and anti-retaliation rules give small pharmacy owners leverage they currently lack against powerful PBMs.
Read twice and referred to the Committee on Finance.
Sent to a congressional committee for expert review. The committee decides whether this bill moves forward.
Introduced in Senate
The bill was officially filed and given a number. It now enters the legislative queue.

The Consolidated Appropriations Act of 2026 introduces new regulations for PBMs, including delinking compensation in Medicare Part D from drug list prices and requiring 'reasonable and relevant' contracts for all pharmacies. Starting in 2028, PBMs must pass through 100% of manufacturer rebates.
President Trump signed the Consolidated Appropriations Act of 2026 on Feb. 3, codifying key PBM reforms. The law restricts Part D remuneration to flat-dollar service fees starting in 2028 and mandates 100% pass-through of rebates to employer plans while strengthening pharmacy network protections.
The $1.2 trillion spending package passed in February 2026 includes a package of reforms for pharmacy benefit managers. These provisions prohibit price-linked remuneration in Medicare Part D, require 100% rebate pass-through, and ensure reasonable pharmacy network contracting standards.
No votes recorded for this bill yet.
Document Type
Congressional Bill
Official Title
Patients Before Middlemen Act
Analysis generated by AI. Always verify with official sources.